Disclosure 0001193125-26-415541-1

SEC FORM 4

$23,169.52

Intellia Therapeutics, Inc. (NTLA)

Sale of 1,864 shares at $12.43 per share.

Reporting Person Dube Michael P · Officer Title VP, Chief Accounting Officer · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001193125-26-415541 · filed 2026-10-06 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Intellia Therapeutics, Inc. (NTLA)." Disclosed 2026-10-06. https://desqlong.com/cards/0001193125-26-415541-1 (retrieved 2026-10-07).